| Anaphylaxis | ||
Christopher A. Smith
| Database Differential Diagnosis Approach to the Patient Data Gathering Physical Examination Laboratory Aids Therapy Follow-Up Common Questions and Answers Bibliography |
| DATABASE | ||
DEFINITION
Anaphylaxis is an explosive antigen specific IgE-mediated response resulting in the release of potent biologically active mediators from mast cells and other inflammatory cells. However, non-IgE mediated direct mast cell degranualtion can result in the same response. Patients may develop any combination of the following symptoms: cutaneous (urticaria/angioedema), respiratory (bronchospasm/laryngeal edema), cardiovascular (hypotension, arrhythmias, myocardial ischemia), and gastrointestinal (nausea, vomiting, pain, diarrhea).
PATHOPHYSIOLOGY
Inducing agents stimulate mast cells to release inflammatory mediators either via an antigen-specific or antigen non-specific manor. These mediators may then act either locally or systemically. Mediator release results in the table Pathophysiology of Anaphylaxis.
Pathophysiology of Anaphylaxis
GENETICS
Atopy can be familial and atopics are at more risk for anaphylaxis.
EPIDEMIOLOGY
COMPLICATIONS
PROGNOSIS
Excellent provided the trigger can be avoided.
| DIFFERENTIAL DIAGNOSIS | ||
GENETIC/METABOLIC
ALLERGIC/IMMUNOLOGICAL
MISCELLANEOUS
COMMON CAUSES
| APPROACH TO THE PATIENT | ||
GENERAL GOAL
Rapidly decide whether the symptoms the patient is experiencing are consistent with anaphylaxis (profuse rhinorrhea, urticaria, wheezing, throat tightness, tachycardia, and hypotension).
Phase 1: Initiate therapy for anaphylaxis. This generally includes: Epinephrine 1:1000 administered subcutaneously, H1 antihistamines, and H2 antihistamines (refractory cases).
Phase 2: Attempt to identify the agent that induced the anaphylactic reaction.
| DATA GATHERING | ||
HISTORY
Question: How long does it take for a patient to react to an offending
allergen?
Significance: Anaphylactic reactions usually begin within
seconds to minutes after contact with offending antigen. This can help the
physician identify the responsible antigen.
Question: Can a patient have an anaphylactic reaction on their first
exposure to an allergen?
Significance: A patient must have had a
previous exposure to the offending allergen for sensitization to occur.
Therefore, anaphylactic reactions should not occur on first exposure.
Question: What does the patient sense during an anaphylactic
reaction?
Significance: Patients commonly describe an impeding doom.
This may be the first sign of an impending anaphylactic reaction.
Question: What organ systems are affected in an anaphylactic
reaction?
Significance: The target organs may include: the heart, the
lungs, the skin and the gastrointestinal tract. Any or all of these target
organs may be affected.
Question: What is the mechanism of fatal
anaphylaxis?
Significance: Death may occur from upper airway
obstruction and/or shock. When treating a patient with anaphylaxis upper airway
obstruction, and hypotension should be taken very seriously.
Question: Has the patient had anaphylaxis in the
past?
Significance: The patient likely knows the responsible allergen.
Efforts should be directed towards allergen avoidance.
Question: Does the patient have autoinjectable
epinephrine?
Significance: Most deaths from anaphylaxis are associated
with delayed administration of epinephrine. Most patients with a history of
anaphylaxis are candidates for autoinjectable epinephrine.
Question: Did the patient experience a bee sting, or are they allergic
to any foods?
Significance: Bee venom allergy can result in
anaphylaxis. It is important to identify the bee (remember honey bees leave
their stinger at the sting site). Immunotherapy is indicated and effective for
Bee venom allergic patients. Any food can cause anaphylaxis, but peanuts, nuts,
and shellfish are notorious.
Question: Does the patient have asthma or heart
disease?
Significance: Asthma and cardiovascular disease are risk
factors for death during anaphylaxis.
Question: Does the patient take any
medications?
Significance: B-blockers make treatment of anaphylaxis
more difficult. Alternative medications should be sought in patients with a
history of anaphylaxis.
| PHYSICAL EXAMINATION | ||
Finding: Angioedema
Significance: May be noted anywhere
during a systemic allergic reaction, but it is much more significant if it
involves the lips, tongue, mouth or larynx (can result in airway
obstruction).
Finding: Urticaria
Significance: Cutaneous manifestation of
a systemic allergic reaction.
Finding: Profuse rhinorrhea
Significance: May signal upper
respiratory tract involvement in a systemic allergic reaction.
Finding: Wheezing
Significance: May signal lower respiratory
tract involvement in a systemic allergic reaction.
Finding: Tachycardia, and hypotension
Significance: May
signal cardiovascular involvement in a systemic allergic reaction. Tachycardia
usually represents a compensatory mechanism in order to maintain the patient’s
blood pressure.
| LABORATORY AIDS | ||
The treatment of anaphylaxis should never be withheld while awaiting laboratory confirmation.
Test: Plasma histamine
Significance: Plasma histamine is
elevated during anaphylaxis.
Test: Serum tryptase
Significance: Serum tryptase becomes
elevated during anaphylaxis.
Test: Complete blood count
Significance: Hemoconcentration
(as judged by an increased hematocrit or hemoglobin) is common as fluid exits
the intravascular space during an anaphylactic reaction.
Test: Chest x-ray
Significance: The bronchospasm associated
with anaphylaxis may result in air trapping and hyperinflated lung fields on
chest x-ray.
Test: ECG
Significance: Anaphylaxis may show rhythm
abnormalities, ischemic changes or infarction on an ECG.
Test: Cardiac enzymes
Significance: Myocardial ischemia
during anaphylaxis may result in a myocardial infarction, and elevated cardiac
enzymes.
REFERRAL
Factors that may help alert you to make a referral include:
| THERAPY | ||
| FOLLOW-UP | ||
| COMMON QUESTIONS AND ANSWERS | ||
Q: When should the autoinjectable epinephrine be used?
A: It
is intended for severe allergic reactions as manifested by any of the following:
bronchospasm, angioedema of the lips or tongue, or hypotension (dizziness). The
patient must seek immediate medical help if the autoinjectable epinephrine is
required.
Q: Do patient’s outgrow this condition?
A: No. Subsequent
reactions tend to have a more rapid onset, and tend to be more severe.
Q: Who should be referred to an allergist?
A: All patients
who have experienced anaphylaxis would benefit from consultation with an
allergist. Patients with anaphylaxis from bee stings, and certain antibiotics
can be desensitized. In addition, the allergist can be helpful in identifying
obscure triggers of anaphylaxis.
| BIBLIOGRAPHY | ||
Atkinson TP, Kaliner MA. Anaphylaxis. Med Clin North Am 1992;76:841–853.
Bochner BS, Lichtenstein LM. Anaphylaxis. N Engl J Med 1991;324:1785–1790.
Cahaly RJ, Slater JE. Latex hypersensitivity in children. Curr Opin Pediatr 1995;7(6):671–675.
Kaliner MA. Anaphylaxis. In: Lockey RF, Bukantz SC, eds. Fundamentals of immunology and allergy. Philadelphia, WB Saunders, 1987:203.
Middleton E, Reed CE, Ellis EF, Adkinson NF, Yunginger JW, Busse WW. Allergy principles and practice, 4th ed. Philadelphia: Mosby, 1993.
Stites DP, Terr AI, Parslow TG. Basic and clinical immunology, 8th ed. Englwood Cliffs: Prentice Hall, 1994.
Copyright
© 2000 Lippincott Williams & Wilkins
M. William
Schwartz, Louis M. Bell, Jr., Peter M. Bingham, Esther K. Chung, David F.
Friedman and Andrew E. Mulberg, The 5 Minute Pediatric Consult